14-24337989-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006871.4(RIPK3):c.716G>A(p.Arg239Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK3 | NM_006871.4 | c.716G>A | p.Arg239Gln | missense_variant | 6/10 | ENST00000216274.10 | NP_006862.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPK3 | ENST00000216274.10 | c.716G>A | p.Arg239Gln | missense_variant | 6/10 | 1 | NM_006871.4 | ENSP00000216274 | P1 | |
RIPK3 | ENST00000554756.1 | c.*58G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/10 | 1 | ENSP00000452328 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251242Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135794
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000564 AC XY: 41AN XY: 727230
GnomAD4 genome AF: 0.000446 AC: 68AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.716G>A (p.R239Q) alteration is located in exon 6 (coding exon 6) of the RIPK3 gene. This alteration results from a G to A substitution at nucleotide position 716, causing the arginine (R) at amino acid position 239 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at